Found: 2
Select item for more details and to access through your institution.
Preclinical Development of PNT6555, a Boronic Acid–Based, Fibroblast Activation Protein-α (FAP)–Targeted Radiotheranostic for Imaging and Treatment of FAP-Positive Tumors.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 1, p. 100, doi. 10.2967/jnumed.123.266345
- By:
- Publication type:
- Article
Pre-clinical studies of EC2629, a highly potent folate- receptor-targeted DNA crosslinking agent.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-69682-9
- By:
- Publication type:
- Article